UniProt ID | EHD1_HUMAN | |
---|---|---|
UniProt AC | Q9H4M9 | |
Protein Name | EH domain-containing protein 1 {ECO:0000305} | |
Gene Name | EHD1 {ECO:0000312|HGNC:HGNC:3242} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 534 | |
Subcellular Localization |
Recycling endosome membrane Peripheral membrane protein Cytoplasmic side . Early endosome membrane Peripheral membrane protein Cytoplasmic side . Cell membrane Peripheral membrane protein Cytoplasmic side . Cell projection, cilium membrane P |
|
Protein Description | ATP- and membrane-binding protein that controls membrane reorganization/tubulation upon ATP hydrolysis. In vitro causes vesiculation of endocytic membranes. [PubMed: 24019528 Acts in early endocytic membrane fusion and membrane trafficking of recycling endosomes] | |
Protein Sequence | MFSWVSKDARRKKEPELFQTVAEGLRQLYAQKLLPLEEHYRFHEFHSPALEDADFDNKPMVLLVGQYSTGKTTFIRHLIEQDFPGMRIGPEPTTDSFIAVMHGPTEGVVPGNALVVDPRRPFRKLNAFGNAFLNRFMCAQLPNPVLDSISIIDTPGILSGEKQRISRGYDFAAVLEWFAERVDRIILLFDAHKLDISDEFSEVIKALKNHEDKIRVVLNKADQIETQQLMRVYGALMWSLGKIINTPEVVRVYIGSFWSHPLLIPDNRKLFEAEEQDLFKDIQSLPRNAALRKLNDLIKRARLAKVHAYIISSLKKEMPNVFGKESKKKELVNNLGEIYQKIEREHQISPGDFPSLRKMQELLQTQDFSKFQALKPKLLDTVDDMLANDIARLMVMVRQEESLMPSQVVKGGAFDGTMNGPFGHGYGEGAGEGIDDVEWVVGKDKPTYDEIFYTLSPVNGKITGANAKKEMVKSKLPNTVLGKIWKLADVDKDGLLDDEEFALANHLIKVKLEGHELPADLPPHLVPPSKRRHE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MFSWVSKD -------CCCCCCHH | 5.61 | 22814378 | |
6 | Phosphorylation | --MFSWVSKDARRKK --CCCCCCHHHHHHC | 20.68 | 24719451 | |
7 | Ubiquitination | -MFSWVSKDARRKKE -CCCCCCHHHHHHCC | 45.87 | - | |
27 | Ubiquitination | TVAEGLRQLYAQKLL HHHHHHHHHHHHHHC | 43.82 | - | |
29 | Phosphorylation | AEGLRQLYAQKLLPL HHHHHHHHHHHHCCH | 9.92 | 23403867 | |
32 | Ubiquitination | LRQLYAQKLLPLEEH HHHHHHHHHCCHHHH | 43.76 | 21890473 | |
40 | Phosphorylation | LLPLEEHYRFHEFHS HCCHHHHHCHHCCCC | 20.46 | - | |
46 | Ubiquitination | HYRFHEFHSPALEDA HHCHHCCCCCCCCCC | 29.86 | - | |
54 | Phosphorylation | SPALEDADFDNKPMV CCCCCCCCCCCCCEE | 64.85 | - | |
69 | Phosphorylation | LLVGQYSTGKTTFIR EEEEEECCCCCHHHH | 37.45 | - | |
124 | Ubiquitination | DPRRPFRKLNAFGNA CCCCCCHHCHHHHHH | 46.61 | - | |
138 | Ubiquitination | AFLNRFMCAQLPNPV HHHHHHHHCCCCCCC | 1.69 | - | |
150 | Phosphorylation | NPVLDSISIIDTPGI CCCCCEEEEECCCCC | 19.90 | 28348404 | |
154 | Phosphorylation | DSISIIDTPGILSGE CEEEEECCCCCCCCC | 17.01 | 28348404 | |
159 | Phosphorylation | IDTPGILSGEKQRIS ECCCCCCCCCHHHHC | 42.88 | 28348404 | |
162 | Ubiquitination | PGILSGEKQRISRGY CCCCCCCHHHHCCCC | 48.69 | - | |
176 | Ubiquitination | YDFAAVLEWFAERVD CCHHHHHHHHHHHCC | 33.67 | - | |
208 | Sumoylation | SEVIKALKNHEDKIR HHHHHHHHCCHHHHH | 62.20 | - | |
219 | Ubiquitination | DKIRVVLNKADQIET HHHHHEEEHHHHHHH | 26.34 | - | |
220 | Ubiquitination | KIRVVLNKADQIETQ HHHHEEEHHHHHHHH | 49.53 | 21890473 | |
222 | Sumoylation | RVVLNKADQIETQQL HHEEEHHHHHHHHHH | 52.15 | - | |
226 | Phosphorylation | NKADQIETQQLMRVY EHHHHHHHHHHHHHH | 24.20 | 20860994 | |
230 | Sulfoxidation | QIETQQLMRVYGALM HHHHHHHHHHHHHHH | 2.06 | 21406390 | |
233 | Phosphorylation | TQQLMRVYGALMWSL HHHHHHHHHHHHHHH | 6.06 | 20068231 | |
234 | Ubiquitination | QQLMRVYGALMWSLG HHHHHHHHHHHHHHH | 14.91 | - | |
239 | Phosphorylation | VYGALMWSLGKIINT HHHHHHHHHHHHHCC | 17.18 | 20068231 | |
240 | Phosphorylation | YGALMWSLGKIINTP HHHHHHHHHHHHCCH | 4.84 | - | |
246 | Phosphorylation | SLGKIINTPEVVRVY HHHHHHCCHHHEEEE | 15.49 | 20068231 | |
260 | Phosphorylation | YIGSFWSHPLLIPDN EECCCCCCCEECCCC | 13.97 | 20068231 | |
280 | Ubiquitination | AEEQDLFKDIQSLPR HHHHHHHHHHHHCCH | 62.31 | 21890473 | |
284 | Phosphorylation | DLFKDIQSLPRNAAL HHHHHHHHCCHHHHH | 40.45 | 30266825 | |
294 | Ubiquitination | RNAALRKLNDLIKRA HHHHHHHHHHHHHHH | 4.95 | - | |
298 | Phosphorylation | LRKLNDLIKRARLAK HHHHHHHHHHHHHHH | 2.94 | - | |
307 | Ubiquitination | RARLAKVHAYIISSL HHHHHHHHHHHHHHH | 16.47 | - | |
312 | Phosphorylation | KVHAYIISSLKKEMP HHHHHHHHHHHHHCC | 21.76 | 24719451 | |
313 | Ubiquitination | VHAYIISSLKKEMPN HHHHHHHHHHHHCCC | 33.52 | - | |
315 | Acetylation | AYIISSLKKEMPNVF HHHHHHHHHHCCCCC | 48.94 | 25953088 | |
324 | Acetylation | EMPNVFGKESKKKEL HCCCCCCCHHHHHHH | 47.56 | 23236377 | |
326 | Phosphorylation | PNVFGKESKKKELVN CCCCCCHHHHHHHHH | 53.94 | 28857561 | |
327 | Acetylation | NVFGKESKKKELVNN CCCCCHHHHHHHHHH | 69.80 | 24886937 | |
328 | Ubiquitination | VFGKESKKKELVNNL CCCCHHHHHHHHHHH | 61.84 | - | |
329 | Ubiquitination | FGKESKKKELVNNLG CCCHHHHHHHHHHHH | 61.08 | - | |
330 | Ubiquitination | GKESKKKELVNNLGE CCHHHHHHHHHHHHH | 67.82 | - | |
338 | Ubiquitination | LVNNLGEIYQKIERE HHHHHHHHHHHHHHH | 4.13 | - | |
339 | Phosphorylation | VNNLGEIYQKIEREH HHHHHHHHHHHHHHH | 10.23 | - | |
341 | Acetylation | NLGEIYQKIEREHQI HHHHHHHHHHHHHCC | 29.57 | 25953088 | |
341 | Ubiquitination | NLGEIYQKIEREHQI HHHHHHHHHHHHHCC | 29.57 | - | |
349 | Phosphorylation | IEREHQISPGDFPSL HHHHHCCCCCCCHHH | 19.09 | 23403867 | |
353 | Phosphorylation | HQISPGDFPSLRKMQ HCCCCCCCHHHHHHH | 5.69 | - | |
355 | Ubiquitination | ISPGDFPSLRKMQEL CCCCCCHHHHHHHHH | 40.58 | - | |
355 | Phosphorylation | ISPGDFPSLRKMQEL CCCCCCHHHHHHHHH | 40.58 | 29255136 | |
363 | Phosphorylation | LRKMQELLQTQDFSK HHHHHHHHHCCCHHH | 5.22 | - | |
369 | Phosphorylation | LLQTQDFSKFQALKP HHHCCCHHHHHHHCH | 40.63 | - | |
372 | Ubiquitination | TQDFSKFQALKPKLL CCCHHHHHHHCHHHH | 49.90 | - | |
375 | Acetylation | FSKFQALKPKLLDTV HHHHHHHCHHHHHCH | 43.02 | 25953088 | |
375 | Malonylation | FSKFQALKPKLLDTV HHHHHHHCHHHHHCH | 43.02 | 26320211 | |
384 | Ubiquitination | KLLDTVDDMLANDIA HHHHCHHHHHHHHHH | 29.65 | - | |
385 | Sulfoxidation | LLDTVDDMLANDIAR HHHCHHHHHHHHHHH | 3.09 | 30846556 | |
389 | Ubiquitination | VDDMLANDIARLMVM HHHHHHHHHHHHHHH | 30.25 | - | |
404 | Sulfoxidation | VRQEESLMPSQVVKG HHCCCCCCCHHEECC | 4.12 | 21406390 | |
417 | Phosphorylation | KGGAFDGTMNGPFGH CCCCCCCCCCCCCCC | 14.87 | 27307780 | |
426 | Phosphorylation | NGPFGHGYGEGAGEG CCCCCCCCCCCCCCC | 13.31 | 27307780 | |
447 | Phosphorylation | VVGKDKPTYDEIFYT EECCCCCCCCEEEEE | 49.71 | 21945579 | |
448 | Phosphorylation | VGKDKPTYDEIFYTL ECCCCCCCCEEEEEC | 21.80 | 21945579 | |
453 | Phosphorylation | PTYDEIFYTLSPVNG CCCCEEEEECCCCCC | 16.66 | 21945579 | |
454 | Phosphorylation | TYDEIFYTLSPVNGK CCCEEEEECCCCCCE | 15.26 | 21945579 | |
456 | Phosphorylation | DEIFYTLSPVNGKIT CEEEEECCCCCCEEC | 20.99 | 25159151 | |
463 | Phosphorylation | SPVNGKITGANAKKE CCCCCEECCCHHHHH | 33.45 | 26074081 | |
467 | Phosphorylation | GKITGANAKKEMVKS CEECCCHHHHHHHHC | 24.62 | 15592455 | |
468 | Phosphorylation | KITGANAKKEMVKSK EECCCHHHHHHHHCC | 49.42 | 18691976 | |
470 | Phosphorylation | TGANAKKEMVKSKLP CCCHHHHHHHHCCCC | 48.80 | 18691976 | |
474 | Phosphorylation | AKKEMVKSKLPNTVL HHHHHHHCCCCCCHH | 28.19 | 28060719 | |
475 | Ubiquitination | KKEMVKSKLPNTVLG HHHHHHCCCCCCHHH | 63.35 | - | |
479 | Phosphorylation | VKSKLPNTVLGKIWK HHCCCCCCHHHHHHH | 18.37 | 21815630 | |
483 | Acetylation | LPNTVLGKIWKLADV CCCCHHHHHHHHHCC | 41.03 | 25953088 | |
483 | Malonylation | LPNTVLGKIWKLADV CCCCHHHHHHHHHCC | 41.03 | 26320211 | |
486 | Acetylation | TVLGKIWKLADVDKD CHHHHHHHHHCCCCC | 36.95 | 26051181 | |
489 | Ubiquitination | GKIWKLADVDKDGLL HHHHHHHCCCCCCCC | 60.63 | - | |
493 | Phosphorylation | KLADVDKDGLLDDEE HHHCCCCCCCCCHHH | 48.81 | - | |
506 | Ubiquitination | EEFALANHLIKVKLE HHHHHHHCEEEEEEC | 24.27 | - | |
523 | Ubiquitination | ELPADLPPHLVPPSK CCCCCCCCCCCCCCC | 40.52 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EHD1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EHD1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EHD1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-456, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-456, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-456, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-456, AND MASSSPECTROMETRY. |